Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea.
Microb Pathog. 2019 Nov;136:103642. doi: 10.1016/j.micpath.2019.103642. Epub 2019 Jul 19.
Microbial flocculants are versatile class of novel biomacromolecules with numerous potential industrial applications. This study sought to investigate the antimicrobial, antioxidant, and anti-inflammatory potential of a polysaccharide-based bioflocculant (PBB) extracted from Bacillus subtilis F9. To achieve this, the antioxidant activity of different PBB concentrations(100 μg/mL ̶ 1000 μg/mL) was first examined in vitro using 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl radicals, and superoxide radical scavenging assays. Further, the anti-inflammatory activity of PBB against lipopolysaccharide (LPS; 1 μg/mL)-induced inflammatory mediators released from headkidney (HK)-derived macrophages of Labeo rohita was investigated. Our results revealed that the capacities of 800 μg/mL of PBB to scavenge DPPH, hydroxyl radicals, and superoxide radicals were 81.46 ± 1.37%, 66.34 ± 2.63%, and 78.03 ± 2.46%, respectively, which were slightly higher that observed following treatment with 400 μg/mL of the positive control (ascorbic acid). Further, the radical scavenging capacity of PBB was found to steadily increase with increasing concentrations of PBB. Pre-treatment with PBB also inhibited nitric oxide production in a dose-dependent manner. We next examined the effect of PBB on proinflammatory cytokines (TNF-α, and IL-1β) and anti-inflammatory cytokines (IL-10, TGF-β) via qRT-PCR and ELISA. We found that PBB markedly inhibited the LPS-induced mRNA and protein expression levels of TNF-α and IL-1β, while it significantly increased those of IL-10 and TGF-β. Further, PBB exhibited an antibacterial activity against multiple food-borne pathogens with minimal inhibitory concentration values in the range of 3 ̶ 11 mg/mL. Importantly, PBB exhibited negligible cytotoxic effects against HK macrophages. Taken together these results suggest that PBB may serve as a natural antioxidant for application in functional therapies and may also be exploited for its anti-inflammatory potential.
微生物絮凝剂是一类新型的多功能生物大分子,具有许多潜在的工业应用。本研究旨在研究从枯草芽孢杆菌 F9 中提取的多糖基生物絮凝剂 (PBB) 的抗菌、抗氧化和抗炎潜力。为了实现这一目标,首先在体外使用 2,2-二苯基-1-苦基肼 (DPPH)、羟基自由基和超氧自由基清除测定法,研究了不同 PBB 浓度 (100μg/mL-1000μg/mL) 的抗氧化活性。此外,还研究了 PBB 对 LPS (1μg/mL) 诱导的罗非鱼头肾 (HK) 衍生巨噬细胞释放的炎症介质的抗炎活性。结果表明,800μg/mL 的 PBB 清除 DPPH、羟基自由基和超氧自由基的能力分别为 81.46±1.37%、66.34±2.63%和 78.03±2.46%,略高于 400μg/mL 阳性对照 (抗坏血酸) 的观察结果。此外,PBB 的自由基清除能力随着 PBB 浓度的增加而稳定增加。PBB 预处理还以剂量依赖的方式抑制一氧化氮的产生。接下来,我们通过 qRT-PCR 和 ELISA 检查了 PBB 对促炎细胞因子 (TNF-α 和 IL-1β) 和抗炎细胞因子 (IL-10、TGF-β) 的影响。结果表明,PBB 显著抑制了 LPS 诱导的 TNF-α 和 IL-1β 的 mRNA 和蛋白表达水平,而显著增加了 IL-10 和 TGF-β 的表达水平。此外,PBB 对多种食源性病原体表现出抗菌活性,最小抑菌浓度值在 3-11mg/mL 范围内。重要的是,PBB 对 HK 巨噬细胞几乎没有细胞毒性作用。综上所述,这些结果表明 PBB 可作为天然抗氧化剂应用于功能治疗,也可用于抗炎潜力的开发。